Clinical Trials · NCT02545751
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Hangzhou Cancer Hospital
- Enrollment
- 29
- Start date
- Jan 2016
- Locations
- 1 site, China
- Primary endpoint
- The proportion of patients with tumor responses after the initiation of treatment.